Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

WALK Study: Women's Active Living for Koreans Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03681756
Recruitment Status : Recruiting
First Posted : September 24, 2018
Last Update Posted : January 17, 2019
Sponsor:
Information provided by (Responsible Party):
University of California, San Francisco

Brief Summary:
The prevalence of metabolic syndrome (MetS) is a health concern among Asians. Growing evidence indicates that Korean Americans had higher MetS prevalence compared to non-Hispanic Whites, but a culturally and linguistically appropriate lifestyle intervention has not been developed for Korean American middle-aged and older women. Thus, the investigators propose to develop a 4-week lifestyle intervention (Women's Active Living for Koreans (WALK) Study) to increase physical activity (PA) and reduce sedentary behavior for Korean American women.

Condition or disease Intervention/treatment Phase
Physical Activity Metabolic Syndrome Lifestyle, Sedentary Behavioral: WALK Not Applicable

Detailed Description:
The purpose of this pilot study is to develop a 4-week lifestyle intervention (Women's Active Living for Koreans (WALK) Study) to increase physical activity (PA) and reduce sedentary behavior for Korean American women. The investigators will assess feasibility and acceptability of the WALK Study and potential efficacy of the WALK Study on outcomes including sedentary behavior and PA.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Development of a Lifestyle Intervention for Korean American Women at Risk for Metabolic Syndrome
Actual Study Start Date : August 31, 2018
Estimated Primary Completion Date : February 2019
Estimated Study Completion Date : April 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
No Intervention: Group 1
Participants will receive an in-person session and an activity monitor
Experimental: Group 2
Participants will receive an in-person session, an activity monitor, and social support through BAND
Behavioral: WALK
Walking program




Primary Outcome Measures :
  1. Physical activity [ Time Frame: Last 7 days ]
    Time spent in moderate and vigorous activity


Secondary Outcome Measures :
  1. Sedentary behavior [ Time Frame: Last 7 days ]
    Time spent in sedentary activity



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   40 Years to 69 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Self-identified Korean-speaking Korean American women
  • Sedentary lifestyle at work and/or during leisure time
  • Aged between 40 and 69; 4) intention to be physically active
  • KakaoTalk user

Exclusion Criteria

  • Medical conditions or physical problems requiring a special care exercise program
  • Known bone or join problems that impair the ability to do moderate physical activity
  • Participating in a lifestyle modification program or research study
  • Planning a trip out of the U.S. during the next 2 months
  • Pregnancy.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03681756


Contacts
Layout table for location contacts
Contact: Ji Won Choi, RN, PhD (415) 514-2534 JiWon.Choi@ucsf.edu

Locations
Layout table for location information
United States, California
University of California, San Francisco Recruiting
San Francisco, California, United States, 94118
Contact: Juhyun Cho    415-350-4183      
Contact       walk.study@ucsf.edu   
Principal Investigator: JiWon Choi, PhD         
Sponsors and Collaborators
University of California, San Francisco
Investigators
Layout table for investigator information
Principal Investigator: Ji Won Choi, RN, PhD University of California, San Francisco

Layout table for additonal information
Responsible Party: University of California, San Francisco
ClinicalTrials.gov Identifier: NCT03681756     History of Changes
Other Study ID Numbers: 18-24293
First Posted: September 24, 2018    Key Record Dates
Last Update Posted: January 17, 2019
Last Verified: January 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Syndrome
Metabolic Syndrome
Disease
Pathologic Processes
Insulin Resistance
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases